Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection
- 30 April 2009
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 50 (4) , 705-711
- https://doi.org/10.1016/j.jhep.2008.12.021
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Interferon signaling and treatment outcome in chronic hepatitis CProceedings of the National Academy of Sciences, 2008
- Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis CGut, 2007
- Suppressor of cytokine signaling 3 (SOCS3) expression and hepatitis C virus–related chronic hepatitisHepatology, 2007
- Defective Hepatic Response to Interferon and Activation of Suppressor of Cytokine Signaling 3 in Chronic Hepatitis CGastroenterology, 2007
- Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKRGenes & Immunity, 2003
- IFN‐α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling‐3The FASEB Journal, 2003
- Optimal therapy of hepatitis CHepatology, 2002
- Optimal therapy of hepatitis CHepatology, 2002
- Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infectionJournal of Medical Virology, 2002
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995